Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01722136 · ClinicalTrials.gov registry record · NA
"We Walk": Impact of Exercise Dose on Health Outcomes Among Women Ages 60-75
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT01722136: Completed NA study, sponsored by University of South Carolina.
NCT01722136 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01722136, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The overall goal is to determine whether any energy expenditure compensation in response to 16 weeks of aerobic exercise at a higher-dose is greater compared to a lower-dose intervention in older women, and to begin to investigate underlying physiological mechanisms that influence energy expenditure changes in older women.
Interventions
- BEHAVIORAL Low Dosage
- BEHAVIORAL High Dosage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT01722136 record still lists
NCT01722136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Dosage is the first listed.
NCT01722136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01722136 about?
NCT01722136 is a clinical study titled ""We Walk": Impact of Exercise Dose on Health Outcomes Among Women Ages 60-75". The overall goal is to determine whether any energy expenditure compensation in response to 16 weeks of aerobic exercise at a higher-dose is greater compared to a lower-dose intervention in older women, and to begin to investigate underlying physiological mechanisms that influence energy expenditure...
What is the current status of trial NCT01722136?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2012-08. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01722136?
The interventions under investigation include: Low Dosage (BEHAVIORAL), High Dosage (BEHAVIORAL).
Who is sponsoring clinical trial NCT01722136?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01722136's enrollment target sits among peer trials
72 1089th of 2000 higher than 899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia